New combo pill aims to simplify cholesterol management
NCT ID NCT06314919
First seen Nov 01, 2025 · Last updated May 11, 2026 · Updated 29 times
Summary
This study is testing a single pill that combines two medicines (pitavastatin and ezetimibe) to lower cholesterol in people with high cholesterol or mixed lipid problems. About 8,600 participants will take the pill as part of their normal routine, and researchers will check if it helps them reach their target LDL cholesterol levels safely. The goal is to see how well this combination works in real-world conditions, not just in a controlled lab setting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ewha Womans University Seoul Hospital
RECRUITINGSeoul, South Korea
Contact
Conditions
Explore the condition pages connected to this study.